You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 1, 2026
Sale
Calculated transaction value
$20.45K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 30, 2026
Public filing date
Oct 1, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$541.89
Sep 30, 2026
First close after public filing
$541.7
Oct 2, 2026
30-day return after filing
+10.05%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 40 shares @ $511.37
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000153
Filing cohort
Transactions in this filing
Showing 15 of 26
Trades
26
Issuers
1
Estimated value
$5.04M
Buys / sales
0 / 24
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $357.59K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $311K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $19.81K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $42.09K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $21.55K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $259.57K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $501.52K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $196.64K |
| United Therapeutics Corp UTHR Current | Sale | Sep 30, 2026 | $20.45K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $172.2K |
| United Therapeutics Corp UTHR | Exercise | Sep 30, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $76.66K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $288.96K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $77.18K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $39.02K |